NCT03911414View on ClinicalTrials.gov

A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions
Mood DisturbanceMood DisordersNatural SupplementsAlternative Treatment
Interventions
DRUG

Open-label Treatment with Omega-3 Fatty Acids + Inositol

Open-label Treatment with Omega-3 Fatty Acids + Inositol

DRUG

Open-label Treatment with N-acetylcysteine

Open-label Treatment with N-acetylcysteine

Trial Locations (1)

02114-2696

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03911414 - A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth | Biotech Hunter | Biotech Hunter